← Evidence map

ArticleiScience2026

ACSS2 is required for colorectal cancer progression and a druggable target for colorectal cancer treatment.

Lei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42495523